Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Rapid Data Pulses From ASCO 2026: Emerging Data on Oral Targeted Strategies in Breast Cancer
Erica L. Mayer, MD, MPH
22nd Annual Women’s Health Annual Visit (WHAV)
December 04, 2026
New York, New York
Shared Goals, Shared Gains: Align With Patient Preferences
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Target Locked in gMG: Why T2T Matters
Minimal By Design: Define MSE Endpoints
FcRn: Same Class, Different Paths—Spot Agent Differentiators
The IgG Clock: Redose Using IgG Kinetics
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
The 2-Point Signal: Apply ≥2-Point Rule
When to Begin FcRn: Initiation Criteria, Key Evidence
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Lee P. Shulman, MD, FACMG, FACOG
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Linda Bradley, MD
Samantha Denäe
Pre- and Postoperative Use of GnRH Antagonists
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Turning Flares Into Function: Flag Uncontrolled Disease
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
James A. Simon, MD, CCD, NCMP, IF, FACOG
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Sawsan As-Sanie, MD
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Clinical Considerations for the Diagnosis of Endometriosis
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Escalate With Intention: Stepwise, Target-Anchored Moves
The Alloimmune Disorders of Pregnancy
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Kenneth J. Moise Jr., MD
Introduction to Alloimmunization During Pregnancy
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.